Edesa Biotech Extends Dermatitis Study to Canada
Go back to Edesa Biotech Extends Dermatitis Study to Canada| (NASDAQ: EDSA) | Delayed: 4.57 -0.09 (1.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.66 | 52 Week High | $ | |||
| Open | $4.70 | 52 Week Low | $ | |||
| Day High | $4.84 | P/E | N/A | |||
| Day Low | $4.55 | EPS | $ | |||
| Volume | 8,647 | |||||

